3 Publications and Conferences
3.2 Publications
Scientific writing is difficult! For anyone new to scientific writing (or those who have been writing for a long time), PRIDE recommends referring to reporting guidelines published as part of the EQUATOR network (Enhancing the QUAlity and Transparency Of health Research)—an international initiative that seeks to improve the reliability and value of published health research literature. Reporting guidelines promote clear reporting of methods and results to allow critical appraisal of the manuscript. The EQUATOR network has several reporting guidelines for different types of study design, and for many biomedical and health journals, these guidelines are sometimes asked to be submitted as supplemental files along with the main manuscript.
Given the study design of The PRIDE Study, the 2 most common reporting guidelines are:
- Strengthening the reporting of observational studies in epidemiology (STROBE)
- Consolidated criteria for reporting qualitative research (COREQ)
All manuscripts using data from The PRIDE Study are required to be reviewed by The PRIDE Study prior to submission for publication. This is a necessary step to confirm that the submissions are aligned with The PRIDE Study’s mission and match the approved Ancillary Study application. Collaborators (internal or external to PRIDE) should submit their complete manuscript and all associated files for review through our online submission form.
PRIDE requires at least 2 weeks to review manuscripts prior to initial journal submission and at least 1 week to review revisions requested by journals (revise and resubmit). While we recognize that extenuating circumstances may occasionally necessitate expedited review, collaborators are expected to plan proactively to ensure sufficient time for the PRIDE team to provide feedback and for collaborators to incorporate that feedback before submission deadlines.
Once the paper has been submitted, please notify our research team, addressing your email to our PRIDEnet Clinical Research Coordinator Associate, Ell Hundertmark, so that we can keep track of all paper submissions.
3.2.1 Acknowledgements
It is important to acknowledge the contributions of PRIDE participants in sharing their data with The PRIDE Study, collaborators who have supported the research (but do not merit authorship), and funding that supported the research. We provide boilerplate language below that can be adapted for all paper submissions.
Acknowledgements. The PRIDE Study is a community-engaged research project that serves and is made possible by LGBTQIA+ community involvement at multiple points in the research process, including the dissemination of findings. We acknowledge the courage and dedication of The PRIDE Study participants for sharing their stories; the careful attention of PRIDEnet Participant Advisory Committee (PAC) members for reviewing and improving every study application; and the enthusiastic engagement of PRIDEnet Ambassadors and Community Partners for bringing thoughtful perspectives as well as promoting enrollment and disseminating findings. For more information, please visit https://pridestudy.org/pridenet. In acknowledgment of time spent and expertise provided reviewing research, PAC members are provided a stipend for their time.
Funding. This study was partially funded by the Patient-Centered Outcomes Research Institute (PPRN-1501–26848 to MRL) and the National Institute on Drug Abuse of the National Institutes of Health (K24DA057874 to AF). The statements in this manuscript are solely the responsibility of the authors and do not necessarily represent the views of PCORI, its Board of Governors, or its Methodology Committee and the National Institutes of Health.
Conflicts of Interest Disclosures. Dr. Obedin-Maliver has received consultation fees from Ibis Reproductive Health, Hims and Hers Health Inc., Folx Health Inc., Sage Therapeutics and Upstream Inc. on topics unrelated to this work. Dr. Lunn received consultation fees from Hims and Hers Health Inc., Folx Health Inc., Otsuka Pharmaceutical Development and Commercialization Inc., and the American Dental Association on topics unrelated to this work. Dr. Tran received consultation fees from the All of Us Research Program Resources Access Board. No other disclosures were reported.
3.2.3 Preprints
Preprints are versions of scholarly manuscripts that are shared publicly through a preprint server such as bioRxiv, medRxiv, or PsyArXiv before they have undergone formal peer review and been published in a journal. While not required, preprints are one possible option for investigators who are interested in getting their work out sooner. It is important to note that preprints are not peer-reviewed and are potentially subjected to change after going through the journal review process. The general advantage for posting on preprint servers is that these manuscripts will be free for public access, which may be relevant if study findings have time-sensitive policy-related implications, and can be listed on resumes, biosketches, or curriculum vitae for grant applications, job opportunities, or promotion. Commonly used preprint serves include arXiv, medRxiv, PysArXiv, OSF, and Zenodo. Stanford faculty, students, and affiliates may also post preprints in the Stanford Digital Repository.
3.2.4 Research Dissemination Back to LGBTQIA+ Communities
In order to “close the loop” and return value to participants who have contributed their data to The PRIDE Study, we require that all investigators who publish their studies using The PRIDE Study data to complete a community-friendly summary of research findings as part of our dissemination guidelines. This requirement reflects our commitment to community-engaged research and ensures that LGBTQIA+ participants directly benefit from their involvement in the study. The community-friendly summary should be written in accessible, non-technical language that avoids jargon and clearly explains what the research found, why it matters, and how it might impact LGBTQIA+ health and well-being. This process is as follows:
- Notify The PRIDE Study Team. Upon acceptance of the manuscript, contact our our research team (Daniel Moretti, Program Management Director, and Ell Hundertmark, PRIDEnet Clinical Research Coordinator Associate) to notify us of the acceptance and initiate the research dissemination process.
- Complete Community-Friendly Summary. The PRIDE Study team will send a template of the community-friendly summary to the first author for completion within 1 week. Along with the summary, we will request addition information including whether the paper will be open-access, NIH funding support details, anticipated publication date, and final article PDF and citation.
- Collaborative Review and Editing. Our team will review the summary and provide edits as needed to ensure that the language is accessible to participants.
- Dissemination. Once the paper is published, the community-friendly summary will be shared with PRIDE Study participants via email and posted on our website. Examples of previous summaries can be found on our website.
3.3 Conferences
Any abstract submissions to conferences that use data from The PRIDE Study are required to be reviewed by The PRIDE Study prior to submission. The PRIDE Study requests at least 1 week in order to provide feedback. First authors of all abstracts should share their abstracts to all co-authors via email while copying The PRIDE Study research team.
For trainees that are under the direct mentorship of one of The PRIDE Study co-directors, it is recommended that they reach out to their mentor with ample time in order to discuss funding options to attend the conference.
3.4 Resources
Van Lissa CJ, Brandmaier AM, Brinkman L, et al. WORCS: A workflow for open reproducible code in science. Data Science. 2021;4(1):29-49. doi:10.3233/DS-210031
Nowok, B., Raab, G.M and Dibben, C. synthpop: Bespoke creation of synthetic data in R. Journal of Statistical Software. 2016:74(11):1-26. doi:10.18637/jss.v074.i11 .